ID   SBA-6
AC   CVCL_A2CP
DR   cancercelllines; CVCL_A2CP
DR   Cosmic; 2823113
DR   Wikidata; Q105510977
RX   PubMed=30352910;
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Val842Ile (c.2524G>A); ClinVar=VCV000375994; Zygosity=Unspecified (PubMed=30352910).
DI   NCIt; C7888; Small intestinal adenocarcinoma
DI   ORDO; Orphanet_104075; Adenocarcinoma of the small instestine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
RX   PubMed=30352910; DOI=10.1158/1078-0432.CCR-18-1480; PMCID=PMC6335167;
RA   Adam L., San Lucas F.A., Fowler R., Yu Y., Wu W.-H., Liu Y.-L.,
RA   Wang H.-M., Menter D., Tetzlaff M.T., Ensor J. Jr., Manyam G.,
RA   Arold S.T., Huff C., Kopetz S., Scheet P., Overman M.J.;
RT   "DNA sequencing of small bowel adenocarcinomas identifies targetable
RT   recurrent mutations in the ERBB2 signaling pathway.";
RL   Clin. Cancer Res. 25:641-651(2019).
//